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The maintenance of T cell population size is 
controlled by two forms of apoptosis, one that 
is  initiated  by  permeabilization  of  the  mito-
chondrial outer membrane and propagated by 
the release of cytochrome c and another that is 
initiated by death receptor ligation (Green, 2005). 
Engaged death receptors in turn bind Fas- 
associated protein with death domain (Fadd) and 
activate the initiator cysteine protease caspase 8. 
These interactions unleash the cascade of pro-
teolytic events performed by executioner cas-
pases. The manner in which these two forms of 
apoptosis regulate various aspects of T cell de-
velopment and homeostasis is still being studied.
In the course of exploring a role for death 
receptor–mediated apoptosis in T cell population 
dynamics, another form of cell death emerged. 
T cells deficient for Fadd or caspase 8 might 
have been expected to expand to abnormally 
high levels in response to T cell antigen recep-
tor (TCR)-mediated stimulation, and yet, such 
T cells proliferate poorly in culture and exhibit 
little expansion in vivo in response to viral in-
fection (Hedrick et al., 2010). The cause of this 
defect has been controversial. One study char-
acterized human and mouse T cells deficient 
for caspase 8 and concluded that they do not 
activate the prosurvival NF-B pathway (Su 
et al., 2005), although this has been contested 
for mouse T cells and B cells deficient in either 
Fadd or caspase 8 (Salmena et al., 2003; Arechiga 
et al., 2005; Beisner et al., 2005; Imtiyaz et al., 
2006; Ch’en et al., 2008). For example, TCR-
stimulated mouse T cells with an inactivated 
Casp8 gene exhibit normal degradation of IB, 
nuclear localization of RelA, normal induction 
of active NF-B dimers as measured by elec-
trophoretic mobility shift assay, and no differ-
ences in the induction of NF-B target genes. 
Other studies have suggested that there is a cell 
cycle progression defect in Fadd- or caspase   
8–deficient T cells (Zhang et al., 2001; Arechiga 
et al., 2007), and yet, by several criteria, caspase 
8-deficient and wild-type T cells divide at the 
same rate, both in culture and in vivo (Salmena 
et al., 2003; Ch’en et al., 2008).
Experiments  measuring  the  viability  of 
stimulated T cells showed that the deficit in   
T cell expansion caused by a loss of caspase 8 was 
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Cell populations are regulated in size by at least two forms of apoptosis. More recently, 
necroptosis, a parallel, nonapoptotic pathway of cell death, has been described, and this 
pathway is invoked in the absence of caspase 8. In caspase 8–deficient T cells, necropto-
sis occurs as the result of antigen receptor–mediated activation. Here, through a genetic 
analysis, we show that necroptosis in caspase 8–deficient T cells is related neither to the 
programmed necrosis as defined by the requirement for mitochondrial cyclophilin D nor 
to autophagy as defined by the requirement for autophagy-related protein 7. Rather, 
survival of caspase 8–defective T cells can be completely rescued by loss of receptor-
interacting serine-threonine kinase (Ripk) 3. Additionally, complementation of a T cell–
specific caspase 8 deficiency with a loss of Ripk3 gives rise to lymphoproliferative disease 
reminiscent of lpr or gld mice. In conjunction with previous work, we conclude that 
necroptosis in antigen-stimulated caspase 8–deficient T cells is the result of a novel 
Ripk1- and Ripk3-mediated pathway of cell death.
© 2011 Ch’en et al.  This article is distributed under the terms of an Attribu-
tion–Noncommercial–Share Alike–No Mirror Sites license for the first six months 
after the publication date (see http://www.rupress.org/terms). After six months 
it  is  available  under  a  Creative  Commons  License  (Attribution–Noncommer-
cial–Share Alike 3.0 Unported license, as described at http://creativecommons 
.org/licenses/by-nc-sa/3.0/).
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and cyclophilin D might be important for necroptosis associ-
ated with the loss of caspase 8 (Vandenabeele et al., 2010).
To  test  this  possibility,  we  crossed  Casp8f/f  Cd4Cre 
(tCasp8/) mice with mice harboring a Ppif-null allele and 
generated four genotypes for analysis: Casp8f/f (WT), tCasp8/, 
Ppif/, and tCasp8/ Ppif/ (double KO [DKO]) mice. To 
confirm the deletion appropriate to each genotype, purified 
T cells were immunoblotted for caspase 8 and cyclophilin D 
(Fig. S1). As previously shown, tCasp8/ mice have a re-
duced percentage of LN T cells (Salmena et al., 2003), whereas 
Ppif/ mice showed no apparent changes in the proportion or 
number of T and B cells (Fig. 1 A and not depicted). The four 
genotypes showed no differences in the proportion of CD44+ 
memory-effector cells (unpublished data).
To analyze the dynamics of T cell expansion, CFSE-
labeled cells were cultured for 72 h, and collected such that 
the area under each curve is representative of the total ac-
cumulation of cells (Fig. 1 B). In accord with previous results 
(Ch’en et al., 2008), there was a diminished accumulation of 
tCasp8/ CD4+ T cells, although the number of cell divi-
sions was unchanged from wild-type. Ppif/ T cells showed 
no difference from wild-type, but contrary to the prediction 
described above, the loss of Ppif did not rescue the decreased 
viability  found  in  tCasp8/  T  cells.  Similar  results  were 
found for CD8+ T cells (unpublished data).
To test this further, mice were infected with lymphocytic 
choriomeningitis virus (LCMV) Armstrong, and the number 
of  LCMV-specific  T  cells  measured  at  the  peak  of  the   
response, day 9, and at day 14 after a marked contraction of 
the population. As depicted in Fig. 1 C and previously re-
ported, there was little expansion in tCasp8/ mice when 
compared with wild-type mice (Salmena et al., 2003; Ch’en 
et al., 2008). Again, the loss of Ppif did not rescue this di-
minished proliferation (Fig. 1 C). We have also found no   
defects in LCMV-mediated expansion in Ppif/ mice (un-
published data).
Although the mPTP complex has been characterized as 
consisting of the adenosine nucleotide translocator, the volt-
age-dependent anion channel, and cyclophilin D among other 
molecules, only a mutation in Ppif is sufficient to protect against 
ischemia reperfusion injury in vivo (Kokoszka et al., 2004; 
Baines et al., 2007). Such programmed necrosis was thought to 
be synonymous with necroptosis, especially given the finding 
that TNF-induced adenosine nucleotide translocator inhibi-
tion leading to cell death was shown to be Ripk1 dependent 
(Temkin et al., 2006). Notwithstanding these strong connec-
tions, we conclude that Ripk1-dependent necroptosis induced 
in activated T cells does not rely on the activity of cyclophilin 
D. Either this is a form of necroptosis that is distinct from that 
initiated by TNF, or in general, necroptosis does not use the 
pathway involving mPTP formation.
Autophagy and cell death in T cells
Experiments have shown that monocytic cell lines or primary 
macrophages  treated  with  irreversible  caspase  inhibitors   
or with diminished caspase 8 expression spontaneously died. 
clearly explained by a continuous loss in cell viability; how-
ever, the death was not apoptotic. No DNA fragmentation 
was evident, as measured by DNA laddering or TdT-mediated 
dUTP-biotin nick end labeling (TUNEL; Ch’en et al., 2008). 
Other studies have suggested that this death occurred as a re-
sult of overexuberant autophagy (Yu et al., 2004; Bell et al., 
2008), although an RNA interference screen for suppression 
of nonapoptotic death did not uncover autophagy genes 
(Hitomi et al., 2008). Instead of acting to preserve cell viabil-
ity under conditions of starvation, this form of autophagy was 
proposed to give rise to the accumulation of reactive oxygen 
species (Yu et al., 2006).
Other investigations suggested that this death was related 
to that of cells signaled to die through TNFRI, but defective 
for either Fadd or caspase 8 (Schulze-Osthoff et al., 1994). 
This death has been termed necroptosis, and it can be blocked 
by the receptor-interacting serine/threonine-protein kinase 
(Ripk) 1 kinase inhibitor necrostatin-1 (Degterev et al., 2005, 
2008). Consistent with these results, the expansion defect in 
caspase 8–deficient T cells was rescued by necrostatin-1 or a 
knockdown of Ripk1 (Ch’en et al., 2008). As such, it would 
appear that caspase 8 can function as both an initiator of 
apoptosis and an inhibitor of necroptosis; in its absence, perhaps 
a consequence of viral infection, T cells die via necroptosis.
Recent  work  has  suggested  that  Ripk1  and  Ripk3 
function as a complex to induce programmed necrotic cell 
death through the synthesis of reactive oxygen species (Cho   
et al., 2009; He et al., 2009; Zhang et al., 2009). This sug-
gests that in TCR-stimulated caspase 8–deficient T cells, 
necroptotic death is similarly mediated, although a recent 
work could find no evidence for the participation of Ripk3 
in the death associated with the loss of Fadd in T cells 
(Osborn et al., 2010).
In this report, we have investigated T cell death associated 
with a loss of caspase 8 with respect to the role of programmed 
necrosis as defined by the requirement for cyclophilin D, the 
role of autophagy as defined by the requirement for autophagy-
related protein 7 (Atg7), and Ripk3-dependent necroptosis. 
Genetic complementation experiments show that only a loss of 
Ripk3 is able to rescue the expansion of caspase 8–deficient 
T cells and reveal an abnormal CD3+CD4–CD8–B220+ popu-
lation of T cells characteristic of human beings and mice with 
mutations in TNFRSF6 (Fas).
RESULTS AND DISCUSSION
Caspase 8–deficient T cells do not die by classical necrosis
The process of necroptosis, mediated by Ripk1, is thought to 
function through programmed necrosis involving the forma-
tion of a mitochondrial permeability transition pore (mPTP; 
Vandenabeele et al., 2010). For example, both necroptosis 
and ischemia reperfusion death can be blocked by necro-
statin-1 (Degterev et al., 2005, 2008; Ch’en et al., 2008). 
Separate studies showed that mice lacking the Ppif gene en-
coding cyclophilin D, an essential component of the mPTP, 
were also protected from ischemia reperfusion (Baines et al., 
2005; Nakagawa et al., 2005). We thus reasoned that Ripk1 JEM VOL. 208, April 11, 2011  635
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As such, we sought to determine whether a targeted deletion 
of Atg7 could likewise rescue the death associated with the 
loss of caspase 8 in T cell activation.
Mice with a conditional Atg7 deletion (Komatsu et al., 
2005) were crossed with mice bearing Casp8f/f. We gener-
ated the following four genotypes for analysis: Casp8f/f (WT), 
Casp8f/f Cd4Cre (tCasp8/), Atg7f/f Cd4Cre (tAtg7/), and 
Casp8f/f Atg7f/f Cd4Cre (DKO). To confirm the deletion ap-
propriate to each genotype, purified T cells were immuno-
blotted for caspase 8 and Atg7 (Fig. S2 A). Analysis of the 
total T cells and B cells (Fig. S2 B), along with the number and 
proportion of memory–effector T cells (Fig. S2 C) verified 
previously published data showing a loss in T cell viability in 
tAtg7/ mice because of abnormally high numbers of mito-
chondria. We found that the addition of a Casp8-null allele 
accentuated the loss of T cells (Fig. S2 B); at present we do 
not have an explanation for this genetic interaction.
To determine if the proliferation defect in the absence of 
Casp8 is caused by an increase in autophagic death, we char-
acterized proliferation and accumulation of T cells with or 
without the addition of necrostatin-1. Upon stimulation, a   
T cell–specific deficiency in either Casp8 or Atg7 caused re-
duced recovery (Fig. 2 A). The double-mutant T cells exhib-
ited an additional decrease in accumulation, whereas there 
was no defect in the number of cell divisions. With the addi-
tion of necrostatin-1, the accumulation of tCasp8/ T cells 
was rescued as expected, whereas the addition of necrostatin-1 
to tAtg7/ T cells had no effect. The addition of necrostatin-1 
to double-mutant T cells partially restored accumulation, 
presumably overcoming the loss of Casp8 but not Atg7 (Fig. 2, 
A and B). These results show that the decrease in T cell ac-
cumulation caused by an Atg7 loss of function is not depen-
dent on the kinase activity of Ripk1. More importantly, the 
presence of an Atg7 mutant allele did not rescue the necro-
statin-sensitive cell death associated with a loss of caspase 8.
The loss of viability in T cells deficient for Atg7 was shown 
to originate from a build-up of mitochondria and overpro-
duction of reactive oxygen species (Pua et al., 2009). Com-
pared with tAtg7/ T cells, DKO T cells were rescued at a 
substantially greater level with the addition of necrostatin-1, 
and one possible implication of this result is that a caspase 8 
deficiency partially attenuates the loss of Atg7 and the build-
up of mitochondria. To test this, we measured mitochondrial 
mass in T cells using MitoTracker (Fig. 2 C). Indeed, there 
was a decrease in the fluorescence corresponding to the mito-
chondrial mass in T cells with mutations in both Casp8 and 
Atg7 when compared with Atg7-defective T cells.
We next determined if the loss of Atg7 could comple-
ment the loss of Casp8 in the proliferation associated with 
LCMV infection. Mice were infected with LCMV, and 
spleens were collected and analyzed 8 and 14 d after infec-
tion. As shown in Fig. 2 D, there was little accumulation of 
LCMV-specific CD8+ or CD4+ T cells from either tCasp8/ 
or tAtg7/ mice. In addition, T cells from DKO mice also 
did not expand. We note that a hemizygous loss of Atg7 also 
did not complement the Casp8 defect (unpublished data).
An analysis indicated that there was a corresponding increase 
in autophagic vacuoles and that death could be inhibited by 
RNA interference–mediated diminution of the autophagy 
pathway components Atg7 and Beclin-1 (Yu et al., 2004). Simi-
lar results were found for Fadd- or caspase 8–deficient T cells 
using pharmacologic inhibition of phospoinositide 3 kinase or 
an short hairpin RNA knockdown of Atg7 (Bell et al., 2008). 
Figure 1.  Caspase 8–deficient T cells do not die by classical necro-
sis. (A) The percentages of live-gated T and B cells from the lymph nodes 
of WT (Casp8f/f), tCasp8/ (Casp8f/f Cd4Cre), Ppif/ (Casp8f/f Ppif/), 
and DKO (Casp8f/f Ppif/ Cd4Cre) mice were determined by flow cytom-
etry. Data are representative of seven independent experiments. (B) Puri-
fied T cells were labeled with CFSE, and then cultured in media alone or 
stimulated with anti-CD3 and anti-CD28 for 72 h. All cells were resus-
pended in an equal volume and collected for the same amount of time on 
the flow cytometer. The numbers on the ordinate indicate the number of  
T cells per interval of intensity, where the area under the curve equals the 
total number of T cells collected. Data are representative of seven inde-
pendent experiments. (C) Cohorts of mice were infected with LCMV Arm-
strong. On days 9 and 14 after infection, mice were sacrificed, and 
splenocytes were stimulated with LCMV peptides for 5 h in vitro. Intracel-
lular IFN- in gated CD4+ and CD8+ T cells was measured by flow cytom-
etry. Error bars represent the SEM. Data are representative of two 
independent experiments.636 T cell necroptosis pathway | Ch’en et al.
Increased apoptotic death in the absence of Atg7
The analysis of the Atg7 mutation as a means of complement-
ing a loss of caspase 8 is complicated by the diminished viability 
of T cells associated with a defect in autophagy. We therefore 
sought to characterize the form of death occurring as a conse-
quence of a loss of caspase 8, Atg7, or both. As a first analysis, 
we measured the proportion of viable versus dead or dying T 
cells by double staining for Annexin V and 7-aminoactinomy-
cin D (7AAD). Annexin V detects a loss of membrane asym-
metry associated with apoptosis, and 7AAD fluoresces after 
DNA intercalation in cells with a compromised plasma mem-
brane characteristic of the early phases of necrosis. Both of 
these measurements are time-dependent, and all dying cells 
eventually become positive for both Annexin V and 7AAD. 
Cells that do not stain with either dye are viable.
T  cells  cultured  in  the  absence  of  stimulation  undergo 
Bim-dependent apoptosis at a high rate (Marrack and Kappler, 
2004). This apoptosis is greatly diminished in cultures opti-
mally stimulated with agonistic antibodies specific for CD3 
and CD28, and this is illustrated by the analysis of wild-type T 
cells from Casp8f/f mice (Fig. 3 A and Fig. S3 A, WT). As pre-
viously shown, similarly stimulated caspase 8–deficient T cells 
undergo cell death at a higher rate (Fig. 3 A and Fig. S3 A, 
tCasp8/ vs. WT). A previous study showed that T cells di-
rectly explanted from Atg7f/f LckCre mice showed diminished 
viability (Pua et al., 2009); however, in this study we found 
that after 72 h of culture, tAtg7/ T cells displayed a similar or 
increased  viability  compared  with  wild-type  T  cells.  With 
stimulation through CD3 and CD28, the viability was substan-
tially reduced compared with WT T cells (Fig. 2 A and Fig. 3 A, 
tAtg7/), and interestingly, the viability of stimulated DKO T 
cells was further reduced such that they did not display in-
creased viability over the unstimulated controls (Fig. 3 A).
To directly compare the form of death for T cells from 
each genotype, a similar analysis was performed with the addi-
tion of necrostatin-1, or qVD, which is a pan-caspase inhibitor 
highly effective in blocking apoptosis. The addition of necro-
statin-1 diminished death in tCasp8/ T cells, as previously 
described, but had no effect on tAtg7/ T cells (Fig. 3 A). In 
contrast, the addition of qVD rescued tAtg7/ T cells, but had 
no effect on tCasp8/ T cells. Double-mutant T cells exhib-
ited the highest death of all, and this death was partially dimin-
ished with necrostatin-1, but not with qVD. These results 
indicate that the loss of the autophagy pathway did not affect 
Figure 2.  Loss of Atg7 does not rescue caspase 8–deficient T cell 
proliferation. (A) Purified WT (Casp8f/f), tCasp8/ (Casp8f/f Cd4Cre), 
tAtg7/ (Atg7f/f Cd4Cre), and DKO (Casp8f/f Atg7f/f Cd4Cre) T cells were 
labeled with CFSE, and then cultured in media alone or stimulated with 
anti-CD3 and anti-CD28 in the absence or presence of necrostatin-1 
(Nec-1) for 72 h. Flow cytometry analysis was performed as described in 
the legend to Fig. 1 B. Numbers above each curve represent the propor-
tion of recovered cells relative to WT. Data are representative of eight 
independent experiments. (B) Percentage of live T cells was determined 
from proliferation described in A. Data are cumulative from eight  
independent experiments, and error bars indicate the SEM. Asterisks  
indicate a significant difference from the WT control; P < 0.01. (C) Mito-
chondrial mass was measured with MitoTracker Green and percent posi-
tive in tCasp8/, tAtg7/, and DKO T cells versus WT T cells was 
calculated. Data are cumulative from three independent experiments, and 
the bars indicate SEM. (D) Cohorts of mice were infected with LCMV  
Armstrong. On days 8 and 14 after infection, mice were sacrificed and 
splenocytes were stimulated with LCMV peptides for 5 h in vitro. Intra-
cellular IFN- in gated CD4+ and CD8+ T cells was measured by flow  
cytometry. Data are representative of three independent experiments.
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logical conditions, and it is not redundant with the many ex-
amples of defective autophagy found in Atg7-null cells (Komatsu 
and Ichimura, 2010). Whether this alternative pathway is 
involved in cell death is presently unknown. We think it is 
unlikely that this process is involved in the cell death studied 
here, and conclude that caspase 8–deficient T cells die by a 
process that does not require autophagy.
Targeted deletion of Ripk3 rescues caspase  
8–dependent necroptosis
The mechanism by which Ripk1 mediates cell death is not 
understood. The process includes neither DNA fragmentation 
nor caspase activation, but as described in the introduction, in 
cells signaled through TNF, a programmed necrosis occurs 
that requires Ripk1 complexed with Ripk3. The proximal 
cause of death may involve the overproduction of reactive 
oxygen species (Cho et al., 2009; He et al., 2009; Zhang et al., 
2009). To determine whether this applies to T cells stimulated 
to divide through the antigen receptor, we crossed a targeted 
mutation in the Ripk3 gene into the Casp8f/f Cd4Cre strain 
to generate Casp8f/f (WT), Casp8f/f Cd4Cre (tCasp8/), 
Ripk3/,  and  Casp8f/f  Ripk3/  Cd4Cre  (DKO)  mice 
(Newton et al., 2004). To confirm the deletion appropriate to 
each genotype, purified T cells were immunoblotted for cas-
pase 8 and Ripk3 (Fig. S4). The first indication that the Ripk3 
loss of function allele complemented tCasp8/ was that DKO 
mice exhibited lymphadenopathy caused by the expansion of 
a population of abnormal CD3+CD4CD8 T cells that also 
expressed B220—a cell type found in mice with a Fas or FasL 
deficiency (Cohen and Eisenberg, 1991). This population ac-
crued in mice with a double mutation, but not in either single 
KO alone (Fig. 4, A and B), implicating that Ripk3-mediated 
cell death can replace Fas-mediated clearance of naturally oc-
curring B220+ T cells (Mohamood et al., 2008). In addition, 
the presence of the CD3+CD4CD8B220+ T cell popula-
tion was not observed until mice were 8 wk of age.
To determine directly whether the Ripk3 KO can com-
plement a caspase 8 deficiency, T cells were stimulated through 
the necroptosis associated with a loss of caspase 8, and the 
DKO mice maintained a component of death that was elimi-
nated with the addition of necrostatin-1.
To further characterize the form of death displayed by 
Atg7 mutant T cells, we measured DNA fragmentation, a 
defining characteristic of apoptosis. The presence of DNA 
fragmentation, as measured by TUNEL, is accompanied by 
the activation of caspases, most notably, caspase 3. All of the 
death associated with a loss of Atg7 showed hallmarks of 
apoptosis—the cells were positive for TUNEL staining and 
active caspase 3 and the death was completely inhibited with 
the addition of qVD (Fig. 3 B and Fig. S3, A and B). These 
experiments reveal that in the absence of autophagy, stimu-
lated T cells are highly sensitive to death by apoptosis, and 
we presume this sensitivity corresponds with earlier studies 
showing an abnormal increase in mitochondrial mass with 
corresponding increases in oxidative stress (Pua et al., 2009). 
Because we previously showed that tCasp8/ T cells do not 
exhibit hallmarks of apoptosis, mutations in Atg7 or Casp8 
are clearly affecting different pathways.
Previous studies on TNF signaling in the absence of Fadd 
or caspase 8 revealed the induction of autophagy, although 
inhibition of the autophagic signaling components did not 
prevent necroptotic cell death (Degterev et al., 2005). These 
results contrasted with other studies on caspase 8–deficient 
cells that demonstrated a form of cell death dependent on 
components of autophagy (Yu et al., 2004; Bell et al., 2008); 
however, the experiments presented here show that the loss 
of Atg7 does not diminish the necroptotic death associated 
with a loss of caspase 8 in T cells.
A recent work showed that there is an etoposide-gener-
ated autophagy that is Atg5 and Atg7 independent (Nishida 
et al., 2009). It does not include lipidation of LC3 (the mam-
malian Atg8 orthologue), but does require Beclin-1 and a 
Rab9-dependent fusion of the phagophore with vesicles de-
rived from the trans-Golgi and late endosomes. Although it 
was shown to be operative in the clearance of mitochondria 
from developing erythrocytes, it may be rare under physio-
Figure 3.  Increased apoptotic death in the absence of Atg7. Purified T cells were cultured in media alone (Unstim) or stimulated with anti-CD3 and 
anti-CD28 in the absence or presence of necrostatin-1 (Nec-1), qVD, or both for 72 h. Dead cells were detected by staining for Annexin V and 7AAD (A) or 
TUNEL and active caspase 3 (B). Genotypes are abbreviated as listed in legend to Figure 2. Data are cumulative from eight (A) or five (B) independent ex-
periments, bars indicate the SEM, and asterisks indicate a significant difference from the WT control; P < 0.01.638 T cell necroptosis pathway | Ch’en et al.
The cellular pathways of necroptosis, autophagy, and apop-
tosis appear to be highly interconnected, and thus identifying 
a specific pathway can be complicated in different experi-
mental models in which cell death occurs (Vandenabeele et al., 
2010). We have shown that neither programmed necrosis, as 
defined by a requirement for cyclophilin D, nor autophagy, 
as defined by the requirement for Atg7, is operative in the 
necroptosis observed in caspase 8–deficient T cells. Rather, 
necroptosis is a unique death pathway mediated by Ripk1 
and Ripk3 (Cho et al., 2009; He et al., 2009; Zhang et al., 
2009), and here we show that this is the unique cell death 
pathway initiated by TCR-mediated T cell activation in the 
absence of caspase 8. We can deduce that caspase 8 prevents 
CD3 and CD28, and the division and accumulation in culture 
was recorded as described in Fig. 1. As shown, the paucity of 
T cell accumulation of T cells deficient in caspase 8 was res-
cued by the additional genetic deletion of Ripk3 (Fig. 4 C). 
No changes in T cell expansion were noted in T cells with a 
mutant version of Ripk3 alone. Finally, we wished to confirm 
the rescue by determining the expansion of T cells in re-
sponse to LCMV infection. As shown, there was little T cell 
accumulation in the absence of caspase 8, but this phenotype 
was rescued at the peak of the immune response by the 
additional deletion of Ripk3. By 14 d after infection, the con-
traction  of  the  T  cell  population  with  defects  in  either 
Rip3/ or both tCasp8/ and Rip3/ was similar to WT.
Figure 4.  Targeted deletion of Ripk3 rescues caspase 8–dependent necroptosis. (A) Live-gated Casp8f/f Ripk3/ and DKO (Casp8f/f Ripk3/ Cd4Cre) 
lymphocytes from mice of the indicated ages were stained with CD3 and B220. Data are representative of three independent experiments. (B) The number of live-
gated CD3+B220, CD3B220+, and CD3+B220+ cells from the lymph nodes of Ripk3/, Casp8f/f Ripk3/, and DKO mice were determined by flow cytometry. 
Data are cumulative from three independent experiments. Bars indicate the SEM, and asterisks indicate a significant difference from the WT control; P < 0.01.  
(C) Purified T cells were labeled with CFSE and stimulated with anti-CD3 and anti-CD28 for 72 h. Flow cytometry analysis was performed as described in the leg-
end to Fig. 1 B. Data are representative of three independent experiments. (D) Cohorts of mice were infected with LCMV Armstrong. On days 8 and 14 after infec-
tion, mice were sacrificed and splenocytes were stimulated with LCMV peptides for 5 h in vitro. Intracellular IFN- in gated CD4+ and CD8+ T cells was measured 
by flow cytometry. Data for days 8 and 14 after infection are representative of three and one independent experiments, respectively.JEM VOL. 208, April 11, 2011  639
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Ripk3/ mice were generated on a C57BL/6 background. All mice were 
analyzed between 4 and 12 wk of age. Mice were bred and maintained in the 
animal care facilities at the University of California San Diego. Animal proto-
cols were approved by the Institutional Animal Care and Use Committee.
Isolation of T cells. Single-cell suspensions were prepared from lymph 
nodes and spleen. Resting T cells were purified by magnetic separation with 
an autoMACS (Miltenyi Biotec). Biotinylated antibodies specific for B220, 
MHCII, CD11b, and DX5 (eBioscience) were added to the cells, followed 
by the addition of streptavidin microbeads (Miltenyi Biotec). The purity of 
these negatively selected cells was determined to be >95% CD3+ as verified 
by flow cytometry.
In vitro proliferation. Purified T cells were labeled with 0.5 µM CFSE 
(Invitrogen) for 10 min in PBS/0.1% BSA at 37°C and stimulated with 100 ng 
plate-bound  anti-CD3  (145-2C11)  and  1  µg/ml  purified  anti-CD28 
(eBioscience). All cells were resuspended at 106 cells/ml in a 24-well plate. 
Where indicated, 30 µM 7-Cl-O-necrostatin (provided by A. Degterev, 
Tufts University, Medford, MA) or 20 µM Q-VD-OPH (SM Biochemicals 
LLC) was added to the culture.
Flow cytometry. Cells were incubated with the appropriate antibodies for 
15–20 min in FACS buffer (1x PBS, 1% FBS, 10 mM EDTA, and 0.1% 
Azide). FITC-, PE-, and allophycocyanin-conjugated antibodies specific for 
B220, CD3, CD4, CD8, CD44, CD62L, and IFN- were purchased from 
eBioscience. CD8 conjugated to PerCP was purchased from BioLegend. 
Cultured CFSE-labeled cells were resuspended in an equal volume of FACS 
buffer and collected for a constant length of time on the FACSCalibur (BD). 
Flow cytometric analysis was performed using FlowJo software (Tree Star). 
To stain for mitochondrial mass, lymphocytes were incubated for 30 min at 
37°C with MitoTracker Green (Invitrogen) in RPMI 1640 complete media.
LCMV infection. 4–12-wk-old mice were infected by intraperitoneal injec-
tion with 2 × 105 plaque-forming units of LCMV Armstrong in 0.5 ml of PBS. 
At the indicated time points, spleens were harvested from infected and nonin-
fected mice. Splenocytes were stimulated for 5 h in vitro with gp33 and NP396 
peptides, MHC class I–restricted LCMV epitopes or gp61 and NP309 pep-
tides, MHC class II–restricted LCMV epitopes, and Brefeldin A (GolgiStop; 
BD). Cells were labeled with CD4, CD8, and CD44 surface markers, fixed 
and permeabilized with the Cytofix/Cytoperm kit (BD), and then stained for 
intracellular IFN-. Standard error was calculated for each time point.
Cell death assays. Cells were incubated with Annexin V (Invitrogen) in 
Annexin V–binding buffer (140 mM NaCl, 2.5 mM CaCl2, and 10 mM 
Hepes) for 15 min at room temperature. Staining with 7AAD was done on 
unpermeabilized cells in FACS buffer. TUNEL was performed using the   
In situ Cell Death Detection kit TMR red from Roche. To measure intra-
cellular active caspase-3, cells were fixed, permeabilized, and stained accord-
ing to manufacturer’s protocol and measured by flow cytometry (BD).
Western blotting. Purified T cells were lysed on ice with Cell Lysis Buffer 
(Cell Signaling Technology) supplemented with protease and phosphatase 
inhibitors, and spun for 10 min at 4°C. Protein concentrations were deter-
mined using a Bio-Rad protein assay (Bio-Rad Laboratories). 10-15 µg of 
protein was separated on 4–12% or 12% Bis-tris NuPage Gels (Invitrogen), 
transferred to Immobilon-P PVDF membranes (Millipore), and blotted with 
antibodies specific for caspase 8, clone 1G12 (Enzo Life Sciences); cyclophilin D, 
clone E11AE12BD4 (MitoSciences Inc.); ATG7 (Cell Signaling Technol-
ogy); Ripk3 (ProSci Inc.); and PLC (Santa Cruz Biotechnology). Mem-
branes were incubated with a horseradish peroxidase–conjugated antibody to 
the appropriate species and visualized on Hyblot CL Autoradiography Film 
(Denville Scientific Inc.) using the ECL system.
Statistics. Statistical analyses were performed using Prism 4 for Mac (Graph-
Pad Software, Inc.). Error bars represent SEM, and p-values were calculated 
with a two-tailed Student’s t test.
the activation of the Ripk1–Ripk3 axis, and in its absence, 
necroptosis results. As previously discussed, the physiological 
significance of such signaling circuitry may be that the absence 
of caspase 8 activity serves as a pathogen-associated molecular 
pattern indicating the presence of a virally expressed caspase   
inhibitor (Ch’en et al., 2008).
The lymphoproliferative disease found in mice or human 
beings with a germline Fas mutation, lpr disease, is character-
ized by an accumulation of CD3+CD4CD8B220+ cells in 
the peripheral lymphoid organs (Cohen and Eisenberg, 1991; 
Bidère et al., 2006). In a direct comparison with a germline 
deletion of Fas, this disease was not found in C57BL/6 mice 
with a T cell–specific deletion of Fas (Fasf/f Cd4Cre), at least 
up to 8 mo of age (Hao et al., 2004); rather, there was a grad-
ual decline in T and B cell numbers in secondary lymphoid 
organs eventually resulting in complete lymphopenia. The 
genetic background can be determinative because (C57BL/6 
x MRL)F1 hybrid mice with a T cell–specific deletion of Fas 
did manifest lpr-like lymphoproliferation. We have found 
that the tCasp8/ C57BL/6 mice also do not manifest lpr 
disease, or any type of lymphoproliferation, up to at least 1 yr 
of age (unpublished data); however, Salmena and Hakem 
(2005) found an obvious, generalized lymphoproliferation in 
aged Casp8f/f Lck Cre mice from a mixed 129 and C57BL/6 
genetic background. In contrast, tCasp8/ Ripk3/ C57BL/6 
mice displayed a typical lpr-like lymphoproliferative disease, 
which was consistently manifested at 8 wk of age and in-
cluded the expansion of CD3+CD4CD8B220+ cells. We 
interpret this to indicate that, at least in C57BL/6 mice, a loss 
of the extrinsic apoptosis death pathway confined to T cells, 
along with a loss of the necroptosis pathway, is sufficient to 
invoke lpr disease.
Experiments with MRL.Faslpr mice appear to reveal a re-
quirement for dendritic cells in the expansion of T cells lead-
ing to lymphoproliferation (Teichmann et al., 2010), although 
there are substantial complexities to these studies (Platt and 
Randolph, 2010). Clearly, the role of other cell types and 
strain-specific background genes in lymphoproliferation re-
quire further investigation, including the role of necroptosis 
in lymphocyte homeostasis.
In mice, there is a single caspase that is activated via Fas, 
caspase 8, whereas in human beings there is a second down-
stream caspase, caspase 10. Interestingly, human beings deficient 
in caspase 10, but not caspase 8, exhibit lymphoproliferative 
disease (Bidère et al., 2006). This correlation implies that cas-
pase 8 and caspase 10 are not entirely redundant, and specifi-
cally, caspase 8, but not caspase 10, exerts negative control on 
the necroptosis pathway.
MATERIALS AND METHODS
Mice. Ppif/ (encoding cyclophilin D), Casp8f/f, Atg7f/f, and Ripk3/ 
mice were previously described (Newton et al., 2004; Baines et al., 2005; 
Beisner et al., 2005; Komatsu et al., 2005). Ripk3/ mice were provided by 
V. Dixit (Genentech, Inc., South San Francisco, CA). Strains were crossed 
and backcrossed to obtain mice with single and double mutations with or 
without Cd4Cre (Taconic). Ppif/, Casp8f/f, and Atg7f/f strains were at least 
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